logo

For the Inventor, By the Inventor

Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Corporation

Calculating rank
USPTO Granted Patents = 10

% Expired Patents = 30.0

Forward Citations = 65

Loading Chart...
Loading Chart...

31 inventors (with patents filed for the assignee):

goldMedal Richard Eric Olson (3 out of 118 patents)

silverMedal Dean A Wacker (2 out of 50 patents)

bronzeMedal Michael G Yang (2 out of 48 patents)

4.  Douglas G Batt (1 out of 54 patents)

5.  Haisheng Wang (1 out of 28 patents)

6.  John V Duncia (1 out of 55 patents)

7.  Jingwu Duan (1 out of 52 patents)

8.  Gregory R Ott (1 out of 25 patents)

9.  Daniel S Gardner (1 out of 36 patents)

10.  Joseph B Santella (1 out of 51 patents)

11.  Milind Rajopadhye (1 out of 43 patents)

12.  Soo Sung Ko (1 out of 41 patents)

13.  Xiao Tao Chen (1 out of 4 patents)

14.  Robert J Chorvat (1 out of 48 patents)

15.  Parthasarathi Rajagopalan (1 out of 13 patents)


10 patents:

1. 7456278 - Lactams substituted by cyclic succinates as inhibitors of Aβ protein production (2008-11-25),
2. 7390896 - Cyclic malonamides as inhibitors of Aβ protein production (2008-06-24),
3. 7390802 - Substituted lactams as inhibitors of Aβ protein production (2008-06-24),
4. 6969721 - Tricyclic-2-pyridone compounds useful as HIV reverse transcriptase inhibitors (2005-11-29),
5. 6818659 - (2S)-2-amino-4-(2-amino-(3,4,5,6-tetrahydropyrimidin-4-yl) butanoyl and its use in cyclic and acyclic peptides (2004-11-16),
6. 6818648 - Aryloxy- and arylthiosubstituted pyrimidines and triazines and derivatives thereof (2004-11-16),
7. 6720329 - Spiro-cyclic &bgr;-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-&agr; converting enzyme (TACE) (2004-04-13),
8. 6627629 - N-ureidoheterocycloalkyl-piperidines as modulators of chemokine receptor activity (2003-09-30),
9. 6608227 - Benzylcycloalkyl amines as modulators of chemokine receptor activity (2003-08-19),
10. 6555686 - Asymmetric synthesis of quinazolin-2-ones useful as HIV reverse transcriptase inhibitors (2003-04-29),
Company Overview
Bristol-Myers Squibb Pharma Corporation is a global biopharmaceutical company headquartered in Princeton, NJ. It specializes in the discovery, development, and delivery of innovative medicines that address serious diseases, particularly in the fields of oncology, immunology, cardiovascular disease, and fibrosis. The company is committed to advancing science and improving patient outcomes through its extensive research initiatives and collaborations, focusing on both small molecules and biologics to enhance therapeutic options worldwide.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

10 Patents

#78 in Princeton, NJ

#1,104 in New Jersey

#29,922 in US

#56,169 in the World

Princeton, NJ (US)
Princeton, NJ, United States of America

Bristol-Myers Squibb Pharma Corporation

Forward Citations = 65

31 inventors:

goldMedal Richard Eric Olson (3 out of 118 patents)

silverMedal Dean A Wacker (2 out of 50 patents)

bronzeMedal Michael G Yang (2 out of 48 patents)

4.  Douglas G Batt (1 out of 54 patents)

5.  Haisheng Wang (1 out of 28 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Bristol-Myers Squibb Pharma Corporation. Retrieved from https://idiyas.com/company/bristol-myers-squibb-pharma

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…